Search all trials

Find therapies in clinical trials near you – page 32

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Relapsing multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug

Belgium

Participants:18–64 years
Substances:Charcoal, Activated

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Hormone-dependent prostate cancer

Not recruiting

Registered drug

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deutivacaftor

Contact Research Centre

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Not recruiting

Registered drug

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Dextrose Bp

Contact Research Centre

Fungal infection

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Olorofim

Contact Research Centre

Crohn's disease

Not recruiting

Registered drugNo placebo

Long-Term Study of Ustekinumab for Patients with Crohn's Disease Who Previously Lost Response to Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ustekinumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Small cell lung cancer extensive stage

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Investigational

Study of Batoclimab for Treating Patients with Active Thyroid Eye Disease

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Batoclimab

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Find therapies in clinical trials near you – page 32

432 trials match your criteria

Relapsing multiple sclerosis

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Colitis ulcerative

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Hormone-dependent prostate cancer

Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

Gastroenteropancreatic neuroendocrine tumour disease

Study comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin

Cystic fibrosis

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Fungal infection

Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

Crohn's disease

Long-Term Study of Ustekinumab for Patients with Crohn's Disease Who Previously Lost Response to Treatment

Non-small cell lung cancer

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Small cell lung cancer extensive stage

Study of Lurbinectedin and Atezolizumab for Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer

Endocrine ophthalmopathy

Study of Batoclimab for Treating Patients with Active Thyroid Eye Disease

HER2 positive breast cancer

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.